DFT-MEDICINE D5-13-10-2025-MAXEMO

DFT-MEDICINE D5-13-10-2025-MAXEMO

Professional Development

10 Qs

quiz-placeholder

Similar activities

MIOLOGIA GENERAL SESIÓN VIRTUAL

MIOLOGIA GENERAL SESIÓN VIRTUAL

Professional Development

10 Qs

Inducción Pasantes de Enfermería

Inducción Pasantes de Enfermería

Professional Development

13 Qs

Cuestionario adherencia terapéutica

Cuestionario adherencia terapéutica

Professional Development

13 Qs

Seminar Kesehatan Vaksinasi SAAC

Seminar Kesehatan Vaksinasi SAAC

Professional Development

15 Qs

RITM QUIZ BEE No. 3

RITM QUIZ BEE No. 3

Professional Development

10 Qs

Funds: Ch. 12 Death & Dying

Funds: Ch. 12 Death & Dying

Professional Development

10 Qs

PRAU1

PRAU1

Professional Development

10 Qs

KN Khám Da Cơ Xương Trẻ em

KN Khám Da Cơ Xương Trẻ em

Professional Development

15 Qs

DFT-MEDICINE D5-13-10-2025-MAXEMO

DFT-MEDICINE D5-13-10-2025-MAXEMO

Assessment

Quiz

Health Sciences

Professional Development

Medium

Created by

Maxemo Community

Used 1+ times

FREE Resource

AI

Enhance your content

Add similar questions
Adjust reading levels
Convert to real-world scenario
Translate activity
More...

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

The molecular mimicry responsible for carditis following streptococcal pharyngitis involves structural homology between a bacterial surface component and human cardiac myosin. Which virulence factor of Streptococcus pyogenes is the primary driver of this autoimmune cross-reactivity?

M protein

Streptolysin O

Hyaluronidase

Lipopolysaccharide

Answer explanation

The M protein is the key virulence factor whose antigenic domains share homology with human cardiac myosin and valve proteins, leading to the production of cross-reactive antibodies that cause carditis.


2.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

A patient with long-standing, poorly controlled diabetes mellitus and background retinopathy presents with nephrotic-range proteinuria. A renal biopsy shows prominent, acellular, PAS-positive nodules in the mesangial regions of the glomeruli. Which of the following best describes this characteristic lesion?

Kimmelstiel-Wilson lesions

Subepithelial "humps"

"Spike and dome" formation

Linear deposition of IgG

Answer explanation

 Kimmelstiel-Wilson lesions. This is the classic pathognomonic finding for nodular glomerulosclerosis in diabetic nephropathy, characterized by eosinophilic, PAS-positive mesangial nodules, consistent with the clinical history.


3.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

A patient presents with altered mental status and severe metabolic acidosis with a high anion gap after ingesting an unknown substance. He develops acute oliguric renal failure. Urinalysis reveals the presence of envelope-shaped crystals. Which substance is the most likely cause of this presentation?

Ethylene glycol

Methanol

Salicylate

Lithium

Answer explanation

Ingestion of ethylene glycol (found in antifreeze) causes high anion gap metabolic acidosis. Its metabolite, oxalic acid, precipitates with calcium in renal tubules, forming calcium oxalate crystals and causing acute tubular necrosis.


4.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

A patient admitted with septic shock remains hypotensive despite vasopressor support. On day 3, their serum creatinine increases from 0.9 mg/dL to 2.5 mg/dL. A urine sample reveals the following: Urine Sodium: 60 mmol/L, Urine Osmolality: 280 mOsm/kg, and Fractional Excretion of Sodium (FENa): 3%. Urine microscopy is significant for a specific finding. What is the most likely diagnosis?

Acute Tubular Necrosis (ATN)

Pre-renal Azotemia

Acute Interstitial Nephritis (AIN)

Post-renal Obstruction

Answer explanation

The patient’s findings of high urine sodium (>40), low urine osmolality (<350), and high FENa (>2%) in the setting of sepsis-induced hypotension strongly indicate established intrinsic renal damage, characteristic of ATN.


5.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

A patient develops acute kidney injury after an episode of bloody diarrhea, with labs confirming hemolytic uremic syndrome. Administration of which of the following is most likely to worsen the clinical outcome?

Antibiotics

Intravenous fluids

Packed red blood cells

Furosemide

Answer explanation

In Shiga toxin-producing E. coli (STEC)-HUS, antibiotics can lyse bacteria, increasing toxin release and worsening the endothelial injury and subsequent renal failure.

6.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Assertion (A): Warfarin therapy is a significant, non-traditional risk factor for the development of calciphylaxis in patients with end-stage renal disease. Reason (R): Warfarin, a vitamin K antagonist, impairs the gamma-carboxylation of Matrix Gla Protein (MGP), a potent inhibitor of ectopic vascular calcification.

Both A and R are true, and R is the correct explanation of A.

Both A and R are true, but R is NOT the correct explanation of A.

A is true, but R is false.

Both A and R are false.

Answer explanation

The assertion is a known clinical association. The reason provides the precise molecular mechanism: warfarin's antagonism of vitamin K prevents the activation of MGP, a key protein that prevents calcium deposition in vessel walls.


7.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Media Image

A patient with Stage 4 Chronic Kidney Disease is being managed for various complications. Match the clinical problem in List I with its most appropriate corresponding management principle or pathological feature in List II.

1-p, 2-q, 3-r, 4-s

1-q, 2-p, 3-s, 4-r

1-p, 2-r, 3-q, 4-s

1-s, 2-r, 3-p, 4-q

Answer explanation

 anemia of CKD with an ESA (Darbepoetin), hyperphosphatemia with a phosphate binder (Sevelamer), the skin lesions with calciphylaxis (calcific uremic arteriolopathy), and low bicarbonate with metabolic acidosis.



Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?